Viatris Completes Acquisition of Pacira BioSciences

Viatris · Company update · November 17, 2026

The deal adds established treatments for acute postsurgical pain and osteoarthritis knee pain to the company's innovative medicines portfolio.

Read the announcement

AntSpace’s summary of Viatris’s own announcement: read the original.

More updates from Viatris